【Gelesis-Product Plenity】Gelesis Receives $30 Million Plenity Order from Ro

Partner News

18th November, 2021 – Gelesis, Inc. released a piece of news, which is summarized as follows:


Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for the companys first commercial product for weight management, Plenity. Plenity was initially made available through a beta launch in 2020, and demand quickly outpaced supply while Gelesis worked to construct a larger manufacturing facility. Gelesisfirst commercial-scale manufacturing line at the facility is now complete and validated.

As Gelesisexclusive telehealth partner in the U.S., Ro provides patients with access to telehealth options for weight management including the ability to communicate with a healthcare provider and, if safe and appropriate, to receive a prescription for Plenity through myplenity.com and Ros digital clinics. The telehealth experience complements in-person healthcare provider care (available through any provider and powered by GoGoMeds), making it easier for people to seek treatment on their own time and their own terms.

The first month of the beta launch, in October 2020, demand exceeded the limited manufacturing supply. Since then, Gelesis has sold as much product as it can make and nearly 70,000 people have started their weight management journey with Plenity through Ros platform. Ro projects Plenity will have 1,500% YoY revenue growth (Dec. 2020 to Dec. 2021) and anticipates weight management will continue to be among the companys top treatment requests on the Ro platform. From a random sample of 20,000 people taking Plenity, over 90% had tried at least two weight loss methods before Plenity, with previous attempts including weight loss plans, specialized diets, and prescription weight loss medications. Given the widespread frustrations with other weight loss methods as well as the bias, stigmatization, and insurance challenges that often hinder care, Gelesis is committed to expanding access to its weight management treatment. Notably, over 50% of early members surveyed say they would not have otherwise gone to their doctor for a prescription.

Our beta launch demonstrated the high level of pent-up demand for a unique product like Plenity. Ro has been a terrific partner and worked collaboratively with us to build out a patient-centric user experience for people looking for help with their weight,said David Pass, Pharm.D., Chief Operating & Commercial Officer at Gelesis. Each month we have been selling as much as we can make, and with this pre-order and our manufacturing facility coming on-line, we are excited to build on the momentum and help more and more people achieve their goals.

Gelesis and Ro set out on a shared mission to expand access to high-quality treatment for those patients seeking support in weight management goalsand weve done just that for tens of thousands of patients who receive Plenity through Ros platform,said Zachariah Reitano, co-founder and CEO of Ro. Today, we are thrilled to expand this partnership through additional supply of Plenityguaranteeing the ability to help patients across the country with the treatment and the tools they need.


Further information can be found in the Gelesiss Press Release